Home / Lidocaine, Combinations / Canada
CA ATC N01BB52 · updated 2 Nov 2026
Lidocaine, Combinations shortage in Canada
Is there a Lidocaine, Combinations shortage in Canada?
Yes. As of 2 Nov 2026, 3 Lidocaine, Combinations products are reported short in Canada, the first since 14 May 2021. The company estimate for the return is 15 Jun 2027. Main reason: manufacturing problem.
Also short in Austria, Belgium, Norway. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP (50 mL) | TELIGENT OU | 14 May 2021 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP (25X20 ML vial) | PFIZER CANADA ULC | 1 Apr 2026 | 15 Jun 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP (20mL) | HIKMA CANADA LIMITED | 15 Sep 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.